中珠医疗品牌怎么样 申请店铺
2016年6月22日，经湖北省工商行政管理局批准，公司名称由“中珠控股股份有限公司”正式变更为“中珠医疗控股股份有限公司”。7月4日，证券简称由“中珠控股”变更为“中珠医疗”。自此，中珠基本完成战略转型。
中珠医疗控股股份有限公司（原“中珠控股”）前身为湖北潜江制药股份有限公司，是国家眼科用药生产基地及较早的眼科医药上市公司，2001年5月18日在上海交易所挂牌上市（股票代码：600568）。2009年，珠海中珠集团股份有限公司（以下简称“中珠集团”）在取得控股权的基础上，以其持有的优质地产股权认购公司增发股份，使中珠控股成功转型，形成房地产与医药两大板块并举的发展格局。
On June 22, 2016, with the approval of Hubei Administration for Industry and commerce, the company's name was officially changed from "Zhongzhu Holding Co., Ltd." to "Zhongzhu medical Holding Co., Ltd.". On July 4, the abbreviation of securities was changed from "Zhongzhu holding" to "Zhongzhu medical". Since then, China and Zhuhai have basically completed their strategic transformation. Zhongzhu medical Holding Co., Ltd. (formerly known as "Zhongzhu holding"), formerly known as Hubei Qianjiang Pharmaceutical Co., Ltd., is a national ophthalmic medicine production base and an earlier ophthalmic medicine listed company. It was listed on the Shanghai Stock Exchange on May 18, 2001 (Stock Code: 600568). In 2009, Zhuhai Zhongzhu Group Co., Ltd. (hereinafter referred to as "Zhongzhu group") purchased additional shares of the company with its high-quality real estate shares on the basis of holding rights, which made Zhongzhu holding successfully transform and formed a development pattern of simultaneous development of real estate and medicine.
浙公网安备 33011802001999号
